September 17, 2007
GSK Applies for Additional Indication for Arixtra GlaxoSmithKline (GSK) announced on August 29 that it filed on August 24 an additional indication for the antithrombotic agent Arixtra SC Injection 1.5 and 2.5 mg (fondaparinux sodium). The new application filed is...read more